Faculty Bibliography

INTRODUCTION: Historically, venous thromboembolism (VTE) in the setting of elective knee arthroscopy has been considered rare. However, more recently, the rate of deep vein thrombosis (DVT) has been reported to be approxi - mately 10%. With increasing recognition of the potential for the development of thromboembolic events, several random - ized trials have evaluated the efficacy of chemoprophylaxis in reducing the risk of VTE following knee arthroscopy. However, all of these studies have evaluated the efficacy of low molecular weight heparins (LMWH), with reductions in the risk of DVT ranging from 65% to 93%, but with the potential side effect of bleeding. At the present time, there have been no randomized studies reported evaluating the utility of aspirin, an agent with a reportedly lower bleeding risk than LMWH, as pharmacologic prophylaxis against VTE after arthroscopic knee surgery. METHODS: In a single-center, randomized, single-blind prospective trial, the efficacy of aspirin as postopera - tive pharmacologic VTE prophylaxis was evaluated in a low risk population undergoing knee arthroscopy. One hundred seventy patients were randomized to a treatment group of 325 mg of aspirin daily for 14 days postoperatively (66 patients) or to the control group with no intervention (104 patients). Bilateral, whole leg, com - pression venous duplex ultrasonography was performed 10 to 14 days postoperatively to document the incidence of DVT. The primary endpoint of the current study was the development of DVT or pulmonary embolism (PE), and the secondary endpoint was the development of a postoperative complication. RESULTS: The study cohort was comprised of 104 males (61%) and 66 females (39%) with a mean age of 44.4 +/- 14.4 years (range: 18 to 75 years). Within both the aspirin treatment and control groups, the surgical procedures in - cluded meniscectomy, ACL reconstruction, chondroplasty, and meniscus repair. No cases of postoperative deep vein thrombosis (DVT) or pulmonary embolism (PE) were identi - fied in either arm of the study during the observation period. Twenty-three patients experienced a complication, including pain or swelling (9%), residual joint line tenderness (3%), arthrofibrosis (0.6%), and instability after a fall (0.6%). Three patients developed knee swelling, two of them in the aspirin group and one of whom required a knee aspiration. However, there was no difference in the development of complications between the two patient populations (p = 0.76, odds ratio [OR] 1.14, 95% confidence interval [CI] 0.5-2.56). CONCLUSIONS: With no cases of VTE identified in our pa - tient population, the use of aspirin in a low-risk population undergoing arthroscopic knee surgery is not warranted.

PURPOSE: To evaluate whether screening radiographs as part of the initial workup of knee pain impacts clinical decision-making in a sports medicine practice. METHODS: A questionnaire was completed by the attending orthopaedic surgeon following the initial office visit for 499 consecutive patients presenting to the sports medicine centre with a chief complaint of knee pain. The questionnaire documented patient age, duration of symptoms, location of knee pain, associated mechanical symptoms, history of trauma within the past 2 weeks, positive findings on plain radiographs, whether magnetic resonance imaging was ordered, and whether plain radiographs impacted the management decisions for the patient. Patients were excluded if they had prior X-rays, history of malignancy, ongoing pregnancy, constitutional symptoms as well as those patients with prior knee surgery or intra-articular infections. Statistical analyses were then performed to determine which factors were more likely do correspond with diagnostic radiographs. RESULTS: Overall, initial screening radiographs did not change management in 72 % of the patients assessed in the office. The mean age of patients in whom radiographs did change management was 57.9 years compared to 37.1 years in those patients where plain radiograph did not change management (p < 0.0001). Plain radiographs had no impact on clinical management in 97.3 % of patients younger than 40. In patients whom radiographs did change management, radiographs were more likely to influence management if patients were over age forty, had pain for over 6 months, had medial or diffuse pain, or had mechanical symptoms. A basic cost analysis revealed that the cost of a clinically useful radiographic series in a patient under 40 years of age was $7,600, in contrast to $413 for a useful series in patients above the age of 40. CONCLUSION: Data from the current study support the hypothesis that for the younger patient population, routine radiographic imaging as a screening tool may be of little clinical benefit. Factors supporting obtaining screening radiographs include age greater than 40, knee pain for greater than 6 months, the presence of medial or diffuse knee pain, and the presence of mechanical symptoms. LEVEL OF EVIDENCE: II.

Purpose: iBalance high tibial osteotomy, (iHTO, Arthrex Inc, Naples, Florida), is a recently introduced surgical procedure for correction of knee varus malalignment. iHTO, utilizing a polyetheretherketone (PEEK) implant and osteoinductive compounds (OIC), presents challenging post operative radiographs which can easily be misinterpreted as infection. Our purpose is to report, based on review of 24 cases, the previously undescribed to the best of our knowledge, radiographic features of iHTO and its complications. Materials and Methods: Retrospective query of our digital database was performed to identify iHTO cases. The clinical and postsurgical images in all cases with > 1-month follow up imaging were reviewed with attention to 1. Correction of varus malalignment, 2. Healing at the osteotomy site, 3. Changes in the OIC, and 4. Complications. Results: There were 24 iHTOs in 23 patients (17 men, 6 women, ages 21-59, mean 44, median 46), imaged 1 to 29 months post-surgery, with angle of correction, when available, ranging from 5 to 14degree. Immediate post-surgical correction of varus malalignment was seen in 100 % of patients. 100 % depicted oval radiolucencies, at bone PEEK interface simulating erosions and infection. Four, often overlapping, signs of healing were noted: 1. Blurring of bony margins at the osteotomy site, noted within 2 weeks post surgery, 2. Blurring of sharp interface between OIC and host bone, 3. Anterior, posterior and less commonly medial bridging callus, 4. Resorption of OIC, noted as early as 4 months. Complications, seen in 7 cases (29 %), included genu varum recurrence (n = 2), painful exuberant bone formation, (n = 1), and propagation of the osteotomy through the lateral tibial cortex (n = 4). In patients with >6 months follow-up, nonunion and possible infection was seen in 1 patient. 2 patients required total knee arthroplasty due to iHTO failure. Conclusion: iBalance HTO typically depicts oval radiolucencies at the PEEK bone interface not to be mistaken for infection. Familiarity with this features, as well as with other signs of healing, should aid the radiologist in accurate interpretation of post operative films of iHTO patients

Achilles tendon pathology is common and affects athletes and nonathletes alike. The cause is multifactorial and controversial, involving biological, anatomical, and mechanical factors. A variety of conditions characterized by Achilles tendon inflammation and/or degeneration can be clinically and histologically differentiated. These include insertional Achilles tendinopathy, retrocalcaneal bursitis, Achilles paratenonitis, Achilles tendinosis, and Achilles paratenonitis with tendinosis. The mainstay of treatment for all of these diagnoses is nonoperative. There is a large body of evidence addressing treatment of acute and chronic Achilles tendon ruptures; however, controversy remains.

BACKGROUND: Injury to subchondral bone is associated with knee pain and osteoarthritis (OA). A percutaneous calcium phosphate injection is a novel approach in which subchondral bone marrow edema lesions are percutaneously injected with calcium phosphate. In theory, calcium phosphate provides structural support while it is gradually replaced by bone. However, little clinical evidence supports the efficacy of percutaneous calcium phosphate injections. QUESTIONS/PURPOSES: We asked: (1) Does percutaneous calcium phosphate injection improve validated patient-reported outcome measures? (2) What proportion of patients experience failure of treatment (defined as a low score on the Tegner Lysholm Knee Scoring Scale)? (3) Is there a relationship between outcome and age, sex, BMI, and preoperative grade of OA? METHODS: Between September 2012 and January 2014, we treated 33 patients with percutaneous calcium phosphate injections. Twenty-five satisfied our study inclusion criteria; of those, three patients were lost to followup and 22 (88%; 13 men, nine women) with a median age of 53.5 years (range, 38-70 years) were available for retrospective chart review and telephone evaluation at a minimum of 6 months (median, 12 months; range, 6-24 months). Our general indications for this procedure were the presence of subchondral bone marrow edema lesions observed on MR images involving weightbearing regions of the knee associated with localized pain on weightbearing and palpation and failure to respond to conservative therapy (> 3 months). Patients with pain secondary to extensive nondegenerative meniscal tears with a flipped displaced component at the level of bone marrow edema lesions, or with mechanical axis deviation greater than 8 degrees were excluded. All patients had Grades III or IV chondral lesions (modified Outerbridge grading system for chondromalacia) overlying MRI-identified subchondral bone marrow edema lesions. Percutaneous calcium phosphate injection was performed on the medial tibial condyle (15 patients), the medial femoral condyle (five patients), and the lateral femoral condyle (two patients). Concomitant partial meniscectomy was performed in 18 patients. Preoperative and postoperative scores from the Knee Injury and Arthritis Outcome Score (KOOS) and the Tegner Lysholm Knee Scoring Scale were analyzed. RESULTS: For patients available for followup, the outcome scores improved after treatment. The KOOS improved from a mean of 39.5 +/- 21.8 to 71.3 +/- 23 (95% CI, 18.6-45.2; p < 0.001) and the Tegner and Lysholm score from 48 +/- 15.1 to 77.5 +/- 20.6 (95% CI, 18.8-40.2; p < 0.001). However, seven of the 22 patients had poor clinical outcomes as assessed by the Tegner Lysholm Knee Scoring Scale, whereas three had fair results, five had good results, and seven had excellent results. The postoperative Tegner Lysholm score was inversely related to the preoperative Kellgren-Lawrence OA grade (R2 = 0.292; F (1.20) = 9.645; p = 0.006). We found no relationship between outcome scores and age, sex, or BMI. CONCLUSIONS: In a study that would have been expected to present a best-case analysis (short-term followup, loss to followup of patients with potentially unsatisfactory results, and use of invasive cotreatments including arthroscopic debridements), we found that percutaneous calcium phosphate injection in patients with symptomatic bone marrow edema lesions of the knee and advanced OA yielded poor results in a concerning proportion of our patients. Based on these results, we advise against the use of percutaneous calcium phosphate injections for patients with advanced osteoarthritic changes. LEVEL OF EVIDENCE: Level IV, therapeutic study.

Objectives: The purpose of the present study was to determine when patients recover the ability to safely operate the brakes of an automobile following a right knee anterior cruciate ligament reconstruction (ACLR). Methods: A prospective case series of 27 patients who underwent a right knee ACLR, nine with a bone patellar tendon-bone (BPTB) autograft, nine patients who had hamstring (HS) tendon autograft and nine patients who had tibialis anterior (TA) tendon allograft for their reconstructions were tested in a validated computerized driving simulator. At 7-10 days, three weeks, and six weeks post operatively, patients were evaluated with respect to their brake reaction time (BRT), brake travel time (BTT), and total braking time (TBT). Each cohort was then compared with thirty healthy volunteers with similar demographics to establish normative mean values. Results: At 7-10 days post-operatively, all patients had statistically significant differences compared to controls for BRT, BTT, and TBT, regardless of the graft used for the reconstruction. By three weeks postoperatively, those reconstructed with TA allografts demonstrated a return to normal braking parameters with no statistically significant differences compared to controls between BRT, BTT, and TBT, whereas those with BPTB and HS autografts continued to have significant delays in their BTT and TBT with BPTB (p = 0.007, p = 0.009) and HS (p = 0.016, p = 0.015), respectively. By six weeks post-operatively, braking parameters for patients receiving an ACL reconstruction with a hamstring autograft returned to normal values while those treated with a BPTB autograft continued to demonstrate impairment in brake travel time and total braking time compared to controls; however, their brake reaction time had recovered to normative values. Conclusion: Patients who underwent a right knee ACL reconstruction with a TA allograft regained normal braking times by three weeks post-operatively and continued to improve through the six week postoperative time point. In contrast, those treated with a BPTB or HS autograft demonstrated impaired ability to operate motor vehicle brakes three weeks following surgery. While at six weeks, the braking ability of patients treated with hamstring autografts normalized, those receiving a BPTB autograft continued to demonstrate limitations in their brake travel time and total braking time. Patients should be counseled appropriately when discussing reconstruction options and when it is safe to resume driving

Objectives: The purpose of the current study is to investigate the functional strength outcomes of late distal biceps reconstruction using allograft tissue. Methods: Patients who underwent distal biceps reconstruction with allograft tissue between May 2007 and May 2013 were identified. Charts were retrospectively reviewed for post-operative complications, gross flexion and supination strength, and range of motion (ROM). Isokinetic strength and endurance in elbow flexion and forearm supination were measured in both arms. Tests were conducted using a dynamometer at 60o per second for isokinetic strength and 240o per second for endurance. Isometric strength testing was also measured for elbow flexion and forearm supination. Paired t tests were used for statistical analysis. Results: Ten patients with a mean age of 48 years (range 42 - 61 years) were included in the study. Distal biceps reconstruction was performed using an Achilles tendon allograft in 9 patients and a combination of tibialis anterior allograft and gracilis allograft in 1 patient. Of the reconstructions, 50% involved the dominant arm. Full ROM was observed in all patients at the time of their final follow up assessment. The mean followup for dynamometer strength testing was 34 months (range 13-81 months). No statistical differences were noted between data obtained from operative and contralateral extremities. The average peak torque of the operative limb (38.5+/- 5.9 Nm) was 91.7% of that of the contralateral limb (41.8+/-4.9 Nm) in flexion and 93.4% (operative, 5.7+/-1.3 Nm; contralateral, 6.1+/- 1.0 Nm) in supination. No significant differences were found in fatigue index between operative or contralateral limbs for flexion (operative, 34.1+/-17.1%; contralateral, 30.8+/-17.1%; p = 0.29) or supination (operative, 38.2+/-16.5%; contralateral, 42.1+/-11.9%; p = 0.65). The only complication observed was a transient PIN palsy in one patient which resolved by 3 months post-operatively. All patients reported postoperative cosmetic deformity but found their gross appearance acceptable. Conclusion: Late reconstruction for chronic distal biceps rupture using allograft tissue is a safe and effective solution for symptomatic patients with functional demands in forearm supination and elbow flexion. Dynamometer testing shows near normal return of strength and endurance of both elbow flexion and supination following the procedure

OBJECTIVE: The objectives of the article are to improve the radiologist's understanding of shoulder arthroscopy and see how it correlates with MRI. We review the basic principles of arthroscopy followed by a comparison of its strengths and weaknesses relative to MRI. This discussion is supplemented by a series of cases that show the relationship between arthroscopy and MRI in terms of the visualization of normal and abnormal anatomy in the diagnosis of common shoulder abnormalities. CONCLUSION: By understanding what our orthopedic colleagues are seeing (and not seeing) during arthroscopic shoulder surgery, we can better understand the strengths and weaknesses of MRI, which provides us the opportunity to improve our imaging interpretations and produce valuable management-guiding diagnostic reports.

Bone marrow aspirate, prolotherapy, platelet-rich plasma,and autologous conditioned serum represent alternativetreatment options that have emerged to address variousmusculoskeletal ailments. We have reviewed the basicscience, physiology, and clinical evidence of each of thesemodalities and discovered that each treatment has its individualplace in the management of common orthopaedicpathologies. Bone marrow aspirates are successful intreating early arthritis and cartilage defects. Prolotherapyand platelet-rich plasma have demonstrated good efficacyin treating inflammatory processes and early arthritis. Finally,autologous conditioned serum (Orthokine) representsa promising treatment option for chronic joint arthritis. Theclinical evidence supporting these alternative treatmentmodalities is insufficient and further level 1 evidence isneeded before we can begin to employ these techniques inour daily orthopaedic practice.

Throughout the history of orthopaedics, our understandingof the function and necessity of the meniscus has significantlyevolved, and with it, our techniques of treating,repairing, preserving, and replacing it have progressed inparallel. Currently, it is known that a meniscus deficiencyis a predisposing factor to the development of degenerativechanges of the knee. Thus, it is incumbent upon the surgeonto preserve the meniscus to the extent that biology will allow.Unfortunately, circumstances arise when the meniscus cannotbe preserved, and young patients afflicted by irreparablemeniscus deficiency may be potential candidates for a meniscustransplant. Though its indications are limited and itsexecution technically complex, meniscal allograft transplanthas been shown to provide good subjective outcomes and isa potentially joint preserving surgery. This paper provides acomprehensive and historical review of the meniscus, a briefreview of meniscus anatomy and biomechanics, and commentaryon the role of meniscal allograft transplant for thetreatment of meniscal deficiency, including patient selection,graft selection and sizing, surgical technique, and outcomes.